Juan Sanabria
Stock Analyst at BMO Capital
(2.28)
# 2,464
Out of 4,827 analysts
91
Total ratings
56.25%
Success rate
3.43%
Average return
Main Sectors:
Stocks Rated by Juan Sanabria
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ELS Equity LifeStyle Properties | Maintains: Outperform | $78 → $77 | $63.73 | +20.82% | 2 | Apr 22, 2025 | |
SKT Tanger | Initiates: Market Perform | $36 | $29.86 | +20.56% | 1 | Jan 28, 2025 | |
CTRE CareTrust REIT | Downgrades: Market Perform | $34 → $32 | $28.95 | +10.54% | 3 | Dec 9, 2024 | |
OHI Omega Healthcare Investors | Upgrades: Outperform | $45 | $35.55 | +26.58% | 3 | Dec 9, 2024 | |
BRX Brixmor Property Group | Upgrades: Outperform | $30 → $33 | $25.11 | +31.42% | 2 | Dec 6, 2024 | |
CUBE CubeSmart | Downgrades: Market Perform | $50 → $47 | $42.46 | +10.69% | 11 | May 29, 2024 | |
PSA Public Storage | Maintains: Outperform | $325 → $330 | $300.70 | +9.74% | 3 | Mar 19, 2024 | |
NHI National Health Investors | Upgrades: Outperform | $67 | $75.87 | -11.69% | 1 | Mar 12, 2024 | |
PECO Phillips Edison & Company | Maintains: Market Perform | $37 → $40 | $35.23 | +13.54% | 2 | Dec 15, 2023 | |
HR Healthcare Realty Trust | Maintains: Market Perform | $20 → $17 | $15.32 | +10.97% | 1 | Oct 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $38 | $35.82 | +6.09% | 5 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $45 | $34.57 | +30.17% | 1 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $46 | $38.36 | +19.92% | 1 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $70 → $75 | $36.34 | +106.38% | 3 | Dec 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 → $82 | $71.90 | +14.05% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $145 | $95.23 | +52.26% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $100 | $148.25 | -32.55% | 3 | Aug 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $60 | $65.58 | -8.51% | 4 | Aug 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $20 → $21 | $17.88 | +17.45% | 8 | May 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $160 | $147.43 | +8.53% | 7 | May 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $6.94 | +130.55% | 1 | Apr 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $120 → $125 | $163.01 | -23.32% | 1 | Apr 15, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $266 → $273 | $281.65 | -3.07% | 5 | Nov 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.99 | - | 3 | May 18, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $378.03 | - | 6 | Mar 1, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $42.03 | -0.07% | 4 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $197 → $198 | $204.45 | -3.15% | 4 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $103 → $104 | $117.49 | -11.48% | 1 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $76 | $69.68 | +9.07% | 2 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $17.39 | +3.51% | 1 | Mar 8, 2018 |
Equity LifeStyle Properties
Apr 22, 2025
Maintains: Outperform
Price Target: $78 → $77
Current: $63.73
Upside: +20.82%
Tanger
Jan 28, 2025
Initiates: Market Perform
Price Target: $36
Current: $29.86
Upside: +20.56%
CareTrust REIT
Dec 9, 2024
Downgrades: Market Perform
Price Target: $34 → $32
Current: $28.95
Upside: +10.54%
Omega Healthcare Investors
Dec 9, 2024
Upgrades: Outperform
Price Target: $45
Current: $35.55
Upside: +26.58%
Brixmor Property Group
Dec 6, 2024
Upgrades: Outperform
Price Target: $30 → $33
Current: $25.11
Upside: +31.42%
CubeSmart
May 29, 2024
Downgrades: Market Perform
Price Target: $50 → $47
Current: $42.46
Upside: +10.69%
Public Storage
Mar 19, 2024
Maintains: Outperform
Price Target: $325 → $330
Current: $300.70
Upside: +9.74%
National Health Investors
Mar 12, 2024
Upgrades: Outperform
Price Target: $67
Current: $75.87
Upside: -11.69%
Phillips Edison & Company
Dec 15, 2023
Maintains: Market Perform
Price Target: $37 → $40
Current: $35.23
Upside: +13.54%
Healthcare Realty Trust
Oct 6, 2023
Maintains: Market Perform
Price Target: $20 → $17
Current: $15.32
Upside: +10.97%
Dec 16, 2022
Downgrades: Underperform
Price Target: $38
Current: $35.82
Upside: +6.09%
Apr 14, 2022
Initiates: Market Perform
Price Target: $45
Current: $34.57
Upside: +30.17%
Apr 14, 2022
Initiates: Outperform
Price Target: $46
Current: $38.36
Upside: +19.92%
Dec 13, 2021
Upgrades: Outperform
Price Target: $70 → $75
Current: $36.34
Upside: +106.38%
Dec 1, 2021
Upgrades: Outperform
Price Target: $80 → $82
Current: $71.90
Upside: +14.05%
Dec 1, 2021
Upgrades: Outperform
Price Target: $145
Current: $95.23
Upside: +52.26%
Aug 26, 2021
Upgrades: Outperform
Price Target: $100
Current: $148.25
Upside: -32.55%
Aug 26, 2021
Upgrades: Market Perform
Price Target: $60
Current: $65.58
Upside: -8.51%
May 21, 2021
Upgrades: Outperform
Price Target: $20 → $21
Current: $17.88
Upside: +17.45%
May 14, 2021
Downgrades: Market Perform
Price Target: $160
Current: $147.43
Upside: +8.53%
Apr 16, 2021
Initiates: Outperform
Price Target: $16
Current: $6.94
Upside: +130.55%
Apr 15, 2021
Maintains: Market Perform
Price Target: $120 → $125
Current: $163.01
Upside: -23.32%
Nov 16, 2020
Maintains: Buy
Price Target: $266 → $273
Current: $281.65
Upside: -3.07%
May 18, 2020
Downgrades: Underperform
Price Target: n/a
Current: $7.99
Upside: -
Mar 1, 2019
Downgrades: Neutral
Price Target: n/a
Current: $378.03
Upside: -
Jun 8, 2018
Maintains: Buy
Price Target: $41 → $42
Current: $42.03
Upside: -0.07%
Jun 8, 2018
Maintains: Neutral
Price Target: $197 → $198
Current: $204.45
Upside: -3.15%
Jun 8, 2018
Maintains: Buy
Price Target: $103 → $104
Current: $117.49
Upside: -11.48%
Jun 8, 2018
Maintains: Buy
Price Target: $74 → $76
Current: $69.68
Upside: +9.07%
Mar 8, 2018
Maintains: Buy
Price Target: $20 → $18
Current: $17.39
Upside: +3.51%